sample	drug	group path
S1	0	G1	kallisto_170302Leh_D17-2578-2_NA_sequence/abundance.h5
S2	0	G1	kallisto_170302Leh_D17-2578-3_NA_sequence/abundance.h5
S3	1	G1	kallisto_170302Leh_D17-2579-2_NA_sequence/abundance.h5
S4	1	G1	kallisto_170302Leh_D17-2579-3_NA_sequence/abundance.h5
S5	0	G2	kallisto_170302Leh_D17-2590-2_NA_sequence/abundance.h5
S6	0	G2	kallisto_170302Leh_D17-2590-3_NA_sequence/abundance.h5
S7	1	G2	kallisto_170302Leh_D17-2591-2_NA_sequence/abundance.h5
S8	1	G2	kallisto_170302Leh_D17-2591-3_NA_sequence/abundance.h5
